BRIEF published on 06/16/2026 at 21:21, 13 days 23 hours ago Medincell: Key Results and Initiatives for 2025-2026 Innovation Treasury R&D Royalties Medincell
BRIEF published on 05/21/2026 at 19:29, 1 month 9 days ago EMA Accepts Teva's Application for Long-Acting Schizophrenia Treatment Schizophrenia Treatment Teva Pharmaceuticals EMA Approval Olanzapine Injectable Long-acting Formulation
PRESS RELEASE published on 05/21/2026 at 19:24, 1 month 9 days ago Inside Information / Other news releases European Medicines Agency accepts Teva's Marketing Authorization Application for Olanzapine Long-Acting Injectable to treat schizophrenia in adults. Teva and Medincell announce EMA acceptance for innovative treatment option Schizophrenia Medincell Olanzapine Teva EMA
BRIEF published on 04/29/2026 at 13:44, 2 months 1 day ago Impressive sales growth for UZEDY® in Q1 2026 Schizophrenia Medincell Teva Pharmaceuticals UZEDY® Q1 2026 Sales
BRIEF published on 04/29/2026 at 13:44, 2 months 1 day ago UZEDY® Q1 2026 Sales Surge by 62% FDA Approvals Olanzapine LAI UZEDY® Sales Teva Partnership Medincell Growth
PRESS RELEASE published on 04/29/2026 at 13:39, 2 months 1 day ago Inside Information / Other news releases Medincell's partner Teva Pharmaceuticals reports UZEDY Q1 2026 net sales of $63M, a 62% increase year-on-year. Olanzapine LAI NDA accepted by FDA. Medincell focuses on long-acting injectable treatments across various therapeutic areas Medincell Teva Pharmaceuticals Olanzapine LAI UZEDY Long-acting Injectable
BRIEF published on 04/20/2026 at 11:18, 2 months 10 days ago BNP Paribas Développement crosses a threshold at MEDICELL Euronext Paris Voting Rights BNP Paribas Threshold Crossing MEDICELL
BRIEF published on 04/02/2026 at 19:05, 2 months 28 days ago Medincell: Update on capital and voting rights Share Capital Voting Rights Shares Euronext AMF
BRIEF published on 02/20/2026 at 21:42, 4 months 9 days ago Teva's Olanzapine Injectable Suspension Gains FDA Nod Schizophrenia Olanzapine Teva Pharmaceuticals FDA Acceptance Long-acting Injectable
PRESS RELEASE published on 02/20/2026 at 21:37, 4 months 9 days ago Inside Information / Other news releases FDA accepts Teva's NDA for once-monthly olanzapine for schizophrenia treatment, addressing treatment gap. Teva and Medincell collaborate for innovative solution FDA Schizophrenia Medincell Olanzapine Teva
Published on 06/30/2026 at 20:55, 12 minutes ago Clean Air Metals Files Interim Financial Statements for the Three Months Ended April 30, 2026
Published on 06/30/2026 at 18:00, 3 hours 7 minutes ago PPX Mining Announces Resumption of Diamond Drilling Program at the Callanquitas Mine
Published on 06/30/2026 at 15:00, 6 hours 7 minutes ago Four Nines Gold Advances Toward Maiden Drill Program with Property-Wide Geophysical Survey at Hayden Hill
Published on 06/30/2026 at 15:00, 6 hours 7 minutes ago BlackBerry AtHoc Strengthens Enterprise Readiness as Cyber, Climate, and Geopolitical Uncertainty Rises
Published on 06/30/2026 at 15:00, 6 hours 7 minutes ago Presentation at ESPGHAN 2026 Describes Additional Groundbreaking Results of Evaluation of Jaguar Health's Crofelemer as Adjunctive Oral Therapy for the Treatment of Pediatric Intestinal Failure (IF)
Published on 06/30/2026 at 20:43, 24 minutes ago EQS-Adhoc: BayWa AG: Understanding in principle on a concept for adjusting the restructuring agreement with key creditors and major shareholders
Published on 06/30/2026 at 20:16, 51 minutes ago Finexity AG: FINEXITY publishes final figures for the 2025 financial year
Published on 06/30/2026 at 19:15, 1 hour 52 minutes ago 45 years of OHB: From a five-person operation to a leading European space company
Published on 06/30/2026 at 20:52, 15 minutes ago Number of shares and voting rights - May 2026 (In French only)
Published on 06/30/2026 at 18:59, 2 hours 8 minutes ago SUEZ has successfully completed a €600 million green bond issuance
Published on 06/30/2026 at 17:45, 3 hours 22 minutes ago Carrefour completes the sale of Carrefour Romania to Paval Holding
Published on 06/30/2026 at 17:40, 3 hours 27 minutes ago Schneider Electric announces agreement to acquire Cognite, unlocking a new level of strategic intelligence for Industrial AI
Published on 06/30/2026 at 07:30, 13 hours 37 minutes ago Gimv sells its stake in AlpenBlu Clinics (formerly Les Psy Réunis), a Swiss provider of outpatient mental healthcare, to Impact Healthcare.
